Anticorps Monoclonal anti-NeutraKine®IL-27
NeutraKine®IL-27 Monoclonal Antibody for Neutralization, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
Neutralization, ELISA
Conjugaison
Non conjugué
CloneNo.
2H2A2
N° de cat : 69034-1-Ig
Synonymes
Galerie de données de validation
Neutralization |
Informations sur le produit
69034-1-Ig cible NeutraKine®IL-27 dans les applications de Neutralization, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | human HumankineIL-27 protein HZ-1275 |
Nom complet | interleukin 27 |
Symbole du gène | IL-27 |
Identification du gène (NCBI) | 246778 |
Conjugaison | Non conjugué |
Forme | Lyophilized Powder |
Méthode de purification | Purification par protéine G |
Tampon de stockage | Sterile PBS |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
Informations générales
IL-27 is a heterodimeric cytokine composed of two subunits: IL-27a and IL-27b. IL-27 acts on various cell types, including T cells, B cells, macrophages, dendritic cells, natural killer (NK) cells and non-hematopoietic cells. IL-27 plays a critical role in the early regulation of T helper type 1 initiation, and enhances proliferation of naive CD4+T cells and naive B cells. It, however, also exerts anti-inflammatory functions by inhibiting the development of Th17 cells and inducing IL-10 producing type 1 regulatory T cells. IL-27 is a potentially promising cytokine for therapeutic approaches on various human diseases.
This antibody is used to neutralize the bioactivity of IL-27.